Sale!

XIGDUO XR (dapagliflozin; metformin hydrochloride) Drug Profile, 2024

Original price was: $1,199.00.Current price is: $699.00.

XIGDUO XR (dapagliflozin; metformin hydrochloride) drug patents, patent challenges, litigation, SPCs, clinical trials, drug prices, drug prices, suppliers

SKU: XIGDUO XR Category:
Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

XIGDUO XR Drug Profile, 2024 is part of DrugPatentWatch’s deep library of business intelligence on biopharmaceutical drugs.

This definitive guide provides invaluable business insights into every crucial aspect of this medication, addressing the vital points necessary to make business decisions.

Gain key critical insights for XIGDUO XR:

  • United States patents
  • Expired United States patents
  • FDA Paragraph IV patent challenges
  • District Court patent litigation
  • European supplementary protection certificates (SPCs)
  • Clinical trials
  • Drug prices
  • Finished product suppliers

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
Pages

62

Product

XIGDUO XR

DrugPatentWatch - Make Better Decisions
Scroll to Top